Medical News

RSS

BMY announces PEG-Interferon lambda plus ribavirin Phase IIb trial results against HCV

Bristol-Myers Squibb Company today announced results from the Phase IIb EMERGE clinical trial, in which treatment with the investigational compound PEG-Interferon lambda and ribavirin achieved higher rates of rapid virologic response in genotypes 1, 2, 3, and 4, and complete early virologic response in genotypes 1 and 4 than the standard regimen of PEG-Interferon alfa and ribavirin in treatment-naïve patients chronically infected with hepatitis C.

4 Apr 2011

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

Sanofi-aventis announced today that it has successfully completed its exchange offer for all outstanding shares of common stock of Genzyme Corporation.

4 Apr 2011

BMY announces BMS-790052 plus PEG-Interferon alfa and RBV Phase II trial results against HCV

Bristol-Myers Squibb Company today announced results from a Phase II clinical trial in which treatment with the investigational direct-acting antiviral BMS-790052, an NS5A replication complex inhibitor, in combination with PEG-Interferon alfa and ribavirin, achieved sustained virologic response 12 weeks post-treatment in up to 92% of treatment-naïve patients chronically infected with hepatitis C genotype 1.

4 Apr 2011

Study reveals complex influences of different family relationships on child's happiness

Young people's satisfaction with their family situation is clearly related to the quality of relationships with parents and especially their mother's happiness. The research findings come from the first findings from Understanding Society, the world's largest household panel study managed by the Institute for Social and Economic Research at the University of Essex.

4 Apr 2011

Leukemia & Lymphoma publishes CTI's CPOP phase I/II trial results against NHL

Cell Therapeutics, Inc. announced today that the April 2011 edition of the peer reviewed journal, Leukemia & Lymphoma published results of a phase I/II clinical trial evaluating the effect of cyclophosphamide, pixantrone, vincristine, and prednisone in treating patients with aggressive non-Hodgkin's lymphoma who relapsed following initial therapy with cyclophosphamide, doxorubicin, vincristine, and prednisone.

4 Apr 2011

NAA joins with organizations worldwide to raise awareness about autism

The National Autism Association joins with organizations worldwide in recognizing April as Autism Awareness month. With one in 110 children now diagnosed with autism, and autism mortality rates doubling that of the general population, NAA is once again calling upon legislators and government health agencies to declare autism a national health emergency.

4 Apr 2011

$FDA clears Vexim's COHESION bone cement to treat vertebral compression fractures$

FDA clears Vexim's COHESION bone cement to treat vertebral compression fractures

Vexim, the specialist in medical instruments designed for the minimally invasive, anatomical treatment of vertebral compression fractures, today announced that it had been awarded FDA clearance for its new product COHESION, a bone cement for injection into the vertebra following minimally invasive spinal fracture anatomical restoration with the company's SpineJack® device or used in performing a conventional vertebroplasty.

4 Apr 2011

World Medical Device Organization achieves its 100th online course

WMDO, the leading global provider of innovative online training for medical device professionals, announced today that it has achieved its 100th online course.

4 Apr 2011

Therapeutic hypothermia is an effective treatment for young adult patients with HCM

Young adult patients with genetic heart diseases, such as hypertrophic cardiomyopathy, substantially benefitted from therapeutic hypothermia, which could further extend the role for this treatment strategy in new patient populations, according to a scientific presentation at the American College of Cardiology Scientific Sessions in New Orleans, April 1-3.

4 Apr 2011

Researchers develop new way to stimulate neuron production in adult brain

Researchers at Columbia University Medical Center have developed a new way to stimulate neuron production in the adult mouse brain, demonstrating that neurons acquired in the brain's hippocampus during adulthood improve certain cognitive functions.

4 Apr 2011

Routine periodic fasting can reduce risk of coronary heart disease

Fasting has long been associated with religious rituals, diets, and political protests. Now new evidence from cardiac researchers at the Intermountain Medical Center Heart Institute demonstrates that routine periodic fasting is also good for your health, and your heart.

4 Apr 2011

Researchers discover immune system can help predict breast cancer survival

A team of researchers at the University of California, San Francisco has discovered a new way to predict breast cancer survival based on an "immune profile" - the relative levels of three types of immune cells within a tumor. Knowing a patient's profile may one day help guide treatment.

4 Apr 2011

Study finds increased carbapenem use in VA acute care health facilities over the last 5 years

A large, multi-year study of antibiotic use in Veterans Health Administration's acute care facilities demonstrates dramatically increased use of carbapenems, a powerful class of antibiotics, over the last five years.

4 Apr 2011

Study finds high utilization of CTC and Medicare coverage in recent years

Medicare coverage and nationwide utilization of computed tomographic colonography, commonly referred to as virtual colonoscopy, has tripled in recent years, according to a study in the April issue of the Journal of the American College of Radiology.

4 Apr 2011

New research reveals potential treatment for HO in children, soldiers

Promising new research reveals a potentially highly effective treatment for heterotopic ossification, a painful and often debilitating abnormal buildup of bone tissue. HO comes in two main forms—one that appears in children and is congenital, another that strikes wounded military personnel and surgery patients and is triggered by severe injuries and wounds.

4 Apr 2011

Positive results from GDC-0973, GDC-0941 combination therapy Phase I trial against cancer

The combination of two compounds that inhibit two of the most frequently mutated cancer pathways is showing promise in an ongoing Phase I trial, according to data presented at the AACR 102nd Annual Meeting 2011, held here April 2-6.

4 Apr 2011

Scientists identify five new genes that increase risk of developing Alzheimer's

A leading UK scientist's search for factors that increase the risk of developing Alzheimer's has uncovered five new genes to help pinpoint what's going wrong in the brain.

4 Apr 2011

New data: Quadruple therapy can effectively treat patients with HCV

Exciting new data presented today at the International Liver CongressTM 2011 show that quadruple therapy in chronic hepatitis C patients suppressed the emergence of resistant variants and resulted in a 100% rate of sustained virological response - undetectable HCV RNA - 12 weeks after treatment.

4 Apr 2011

Study finds link between smoking and breast cancer risk among non-obese women

Smoking increases the risk of breast cancer, but the risk differs by obesity status in postmenopausal women, according to data from an analysis of the Women's Health Initiative observational study.

4 Apr 2011

Sickle cell trait can cause sudden death in young African-American athletes

The sickle cell trait could be a cause-albeit rare-of sudden death in young African-American competitive athletes, most commonly during football training, according to a scientific poster that will be presented at the American College of Cardiology Scientific Sessions, April 1-3, in New Orleans.

4 Apr 2011

Medical News

BMY announces PEG-Interferon lambda plus ribavirin Phase IIb trial results against HCV

Sanofi-aventis completes exchange offer for all shares of Genzyme common stock

BMY announces BMS-790052 plus PEG-Interferon alfa and RBV Phase II trial results against HCV

Study reveals complex influences of different family relationships on child's happiness

Leukemia & Lymphoma publishes CTI's CPOP phase I/II trial results against NHL

NAA joins with organizations worldwide to raise awareness about autism

FDA clears Vexim's COHESION bone cement to treat vertebral compression fractures

World Medical Device Organization achieves its 100th online course

Therapeutic hypothermia is an effective treatment for young adult patients with HCM

Researchers develop new way to stimulate neuron production in adult brain

Routine periodic fasting can reduce risk of coronary heart disease

Researchers discover immune system can help predict breast cancer survival

Study finds increased carbapenem use in VA acute care health facilities over the last 5 years

Study finds high utilization of CTC and Medicare coverage in recent years

New research reveals potential treatment for HO in children, soldiers

Positive results from GDC-0973, GDC-0941 combination therapy Phase I trial against cancer

Scientists identify five new genes that increase risk of developing Alzheimer's

New data: Quadruple therapy can effectively treat patients with HCV

Study finds link between smoking and breast cancer risk among non-obese women

Sickle cell trait can cause sudden death in young African-American athletes

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News